During the last decade, peptide‐based nanomaterials are recognized as upcoming
biomedical materials for tumor imaging and therapy. The rapid expansion of peptides and …

Since their initial discovery more than 30 years ago, tumor-homing peptides have become
an increasingly useful tool for targeted delivery of therapeutic and diagnostic agents into …

Malignant melanoma is an aggressive skin cancer with poor survival outcomes for patients
diagnosed at an advanced stage. While targeted serine/threonine-protein kinase B-Raf …

The tumor microenvironment in the majority of cancers is known to favor polarization of
tumor-associated macrophages (TAMs) to alternatively activated M2 phenotype, promoting …

The preclinical development of peptidyl drugs for cancer treatment is hampered by their poor
pharmacologic properties and cell penetrative capabilities in vivo. In this study, we report a …

Nanotechnology has played an important role in cancer therapy due to the potential
advantages of nano-drugs including enhanced accumulation in the tumor sites, improved …

Active tumor-targeting approaches using specific ligands have drawn considerable attention
over the years. However, a single ligand often fails to simultaneously target the cancer cell …

Simple Summary The increasing prevalence of malignant diseases and related metastases
warrants the need for the establishment of specific diagnostic vectors that ensure timely as …

Molecular imaging allows direct visualization of targets and characterization of cellular
pathways, as long as a high signal/background ratio can be achieved, which requires a …

Since the approval of bevacizumab as anti-angiogenic therapy in 2004 by the FDA, an array
of angiogenesis inhibitors have been developed and approved. However, results were …